Article: Antares Pharma Announces DPT Laboratories, Ltd. is Preferred Supplier of Transdermal Gel Technologies.

Antares Pharma Inc. (BULLETIN BOARD: ANTR) and DPT Laboratories, Ltd. today announced a letter agreement between the companies whereby DPT will become the preferred development and manufacturing organization for Antares Pharma's transdermal gel products for clients referred to DPT by Antares Pharma.

Commenting on this agreement, Dr. Roger G. Harrison, CEO and President of Antares Pharma, said, "Initiation of this agreement meets one of our stated milestones for 2004. We believe that this arrangement will provide our current and future partners with an assured source of quality products for clinical evaluation and commercialization and will also encourage our ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!